Zobrazeno 1 - 10
of 49
pro vyhledávání: '"P G, Sveshnikov"'
Autor:
Olga D. Hendrickson, Elena A. Zvereva, Vasily G. Panferov, Olga N. Solopova, Anatoly V. Zherdev, Peter G. Sveshnikov, Boris B. Dzantiev
Publikováno v:
Biosensors, Vol 12, Iss 12, p 1137 (2022)
In this study, a lateral flow immunoassay (LFIA) was developed to detect okadaic acid (OA) belonging to the diarrheic shellfish poisoning group of aquatic toxins. Newly obtained anti-OA monoclonal antibodies and bimetallic core@shell Au@Pt nanopartic
Externí odkaz:
https://doaj.org/article/d6c96b66c196470ca48d3b58af971217
Autor:
Olga D. Hendrickson, Elena A. Zvereva, Olga N. Solopova, Anatoly V. Zherdev, Peter G. Sveshnikov, Sergei A. Eremin, Boris B. Dzantiev
Publikováno v:
Micromachines, Vol 13, Iss 9, p 1506 (2022)
In this investigation, a double immunochromatographic analysis (ICA) of two relevant phycotoxins, domoic acid (DA) and okadaic acid (OA), was developed for the first time. The ICA was performed in the indirect competitive format using gold nanopartic
Externí odkaz:
https://doaj.org/article/e3d5ab82cb584c88b5fb302dfa75ff0a
Publikováno v:
Кубанский научный медицинский вестник, Vol 25, Iss 6, Pp 110-113 (2018)
Aim. The research was conducted to study the processes occurring in soft tissues in the surgical treatment of widespread purulent-inflammatory processes of the maxillofacial area and to confirm the effectiveness of the developed optimal surgical tech
Externí odkaz:
https://doaj.org/article/51508be5c49d440ab087174d25e99695
Autor:
Artem E. Medvedchikov, Valentin Yu. Zhilenko, Pavel G. Sveshnikov, Egor V. Burov, Denis Yu. Esin, Evgeniia A. Anastasieva
Publikováno v:
Гений oртопедии, Vol 24, Iss 3, Pp 296-301 (2018)
Distal biceps brachii tendon ruptures are relatively uncommon injuries with numerous surgical exposures and methods of fixation offered for repair. The goal of surgical management is to restore the anatomic footprint of the biceps tendon on the radia
Externí odkaz:
https://doaj.org/article/6543f0bd370d49c09528cabd6dd064b3
Autor:
Vladislav S. Rybchenko, Anna A. Panina, Teimur K. Aliev, Olga N. Solopova, Dmitry S. Balabashin, Valery N. Novoseletsky, Dmitry A. Dolgikh, Petr G. Sveshnikov, Mikhail P. Kirpichnikov
Publikováno v:
Biomolecules, Vol 11, Iss 12, p 1915 (2021)
The main aim of our work was to create a full-length bispecific antibody (BsAb) as a vehicle for the targeted delivery of interferon-beta (IFN-β) to ErbB2+ tumor cells in the form of non-covalent complex of BsAb and IFN-β. Such a construct is a Cro
Externí odkaz:
https://doaj.org/article/d7f2e6622f0f463cb0c401052e6ec978
Publikováno v:
Кубанский научный медицинский вестник, Iss 1, Pp 79-81 (2015)
The dynamics of the process of inflammation and regeneration in the region of pathological sead and in the operating wound when the original surgical treatment of heavy phlegmons of head and neck of odontological and non-odontological origion have be
Externí odkaz:
https://doaj.org/article/50c730b9b06d4daab78fbc02cdfd6957
Publikováno v:
Кубанский научный медицинский вестник, Iss 6, Pp 117-119 (2014)
On the basis of the study, 20 patients with chronic generalized periodontitis of moderate severity, 20 patients with single fractures in the body of the mandible and 20 volunteers with intact periodontium developed a new immunological indicator to di
Externí odkaz:
https://doaj.org/article/1109d4d1a5304b09830a6bb4d497382c
Autor:
D. S. Balabashin, D. A. Dolgikh, A. A. Panina, P. G. Sveshnikov, N. V. Novoseletsky, S. A. Yakimov, V. S. Rybchenko, T. K. Aliev, O. N. Solopova, Mikhail P. Kirpichnikov
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:778-786
Humanization of antibodies for the development of novel therapeutic agents with low immunogenicity remains a topical problem in modern science. In the present work we describe the humanization of murine antibody B16 which binds and neutralizes human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bcc68827f249905714b3ba2182b7c5a
https://doi.org/10.1134/s1068162020050209
https://doi.org/10.1134/s1068162020050209
Autor:
A. A. Panina, V. S. Rybchenko, O. N. Solopova, D. S. Balabashin, S. A. Yakimov, T. K. Aliev, D. A. Dolgikh, P. G. Sveshnikov, M. P. Kirpichnikov
Publikováno v:
Acta Naturae. 12:95-104
The development of and research into new therapies that can selectively and effectively destroy tumor cells that overexpress the ErbB2 receptor is apressing task. Recently, research into the use of type I interferons in the treatment of cancer has in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a73be408728343d2a7b8738579d3270a
https://doi.org/10.32607/actanaturae.11156
https://doi.org/10.32607/actanaturae.11156
Autor:
D. S. Balabashin, V. A. Toporova, P. G. Sveshnikov, T. K. Aliev, A. A. Panina, Mikhail P. Kirpichnikov, V. V. Argentova, O. N. Solopova, V. S. Rybchenko, D. A. Dolgikh, S. A. Yakimov
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:572-581
The development of new therapies for malignant tumors is an urgent task. Currently, the humanized antibody trastuzumab is considered the “gold standard” in the complex treatment of breast tumors with overexpression of HER2, human epidermal growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e28ceefcc0b9f462a2bfb183be475c5e
https://doi.org/10.1134/s1068162020040159
https://doi.org/10.1134/s1068162020040159